OXURION (EBR:OXUR) | Finanzwire

PRESS RELEASE

published on 08/04/2025 at 08:30, 7 months 21 days ago

Oxurion completes the acquisition of Axiodis CRO and accelerates the structuring of its European clinical data platform
Oxurion completes the acquisition of 72% stake in Axiodis CRO, paving the way for an integrated platform focused on clinical data. Intensifies discussions with strategic targets in France and Europe

Acquisition Europe Intégration Clinical Data Oxurion
BRIEF

published on 07/30/2025 at 18:05, 7 months 26 days ago

Oxurion Receives a Modified Transparency Notification

Actions Transparency Biopharmaceutical Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 07/30/2025 at 18:00, 7 months 26 days ago

Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV announces receipt of transparency notification on shareholder ownership crossing under threshold due to selling of voting securities. Press release replaces previous announcement

Transparency Notification Biopharmaceutical Oxurion NV Voting Securities Shareholder Ownership
BRIEF

published on 07/25/2025 at 18:05, 8 months ago

Oxurion Announces Capital Increase via Bond Conversion

Common Shares Capital Increase Biopharmaceuticals Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 07/25/2025 at 18:00, 8 months ago

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Atlas Special Opportunities, LLC converts 10 convertible bonds in Oxurion, resulting in a EUR 250,000 capital increase. Oxurion continues focus on innovative therapeutics for elderly vision preservation

Capital Increase Therapeutics Atlas Special Opportunities Oxurion Vision Preservation
BRIEF

published on 07/24/2025 at 18:05, 8 months 1 day ago

Oxurion capital increase following a bond conversion

Capital Biotechnology Actions Atlas Oxurion
PRESS RELEASE

published on 07/24/2025 at 18:00, 8 months 1 day ago

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Atlas Special Opportunities, LLC converts 7 bonds in Oxurion, leading to EUR 175,000 capital increase. Oxurion focuses on therapeutic innovation to preserve elderly vision

Capital Increase Atlas Special Opportunities Oxurion Therapeutic Innovation Vision Preservation
BRIEF

published on 07/23/2025 at 18:05, 8 months 2 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

Actions Transparency Biopharmaceuticals Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 07/23/2025 at 18:00, 8 months 2 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV announces receipt of transparency notification from Atlas Special Opportunities II, LLC regarding share threshold crossing under Belgian legislation

Transparency Notification Oxurion NV Belgian Legislation Atlas Special Opportunities II LLC Share Threshold
BRIEF

published on 07/22/2025 at 18:05, 8 months 3 days ago

Oxurion NV Receives Transparency Notification from Atlas Special Opportunities II LLC

Transparency Notification Shareholding Atlas Special Opportunities Oxurion NV Belgian Legislation

Published on 03/25/2026 at 13:30, 5 hours 39 minutes ago

Prince Silver Files NI 43-101 Technical Report for Its Stampede Gap Porphyry Copper-Gold-Molybdenum Project in Nevada
Published on 03/25/2026 at 13:30, 5 hours 39 minutes ago

Triera Biosciences - a Zentek Company - Launches Contract Research Organization Services for Custom Aptamer Discovery, Biosensor Enablement, and Machine-Learning Classification
Published on 03/25/2026 at 13:30, 5 hours 39 minutes ago

Strategic Metals Closes Project Sale
Published on 03/25/2026 at 13:25, 5 hours 44 minutes ago

Predictiv AI Expands Active Deployment of CloudRep.ai Across Healthcare, Retail, Real Estate, Travel and Global Markets
Published on 03/25/2026 at 13:20, 5 hours 49 minutes ago

Lobe Sciences Ltd. Reports Improved Financial Position and Strategic Update

View all ACCESSWIRE

Published on 03/25/2026 at 18:40, 28 minutes ago

TULKUBASH AND KYZYLTASH MINING ASSETS: DECLARATION FROM A GROUP OF INVESTORS
Published on 03/25/2026 at 18:30, 39 minutes ago

Amadeus Fire Group confirms preliminary financial figures for the FY 2025 and expects improved results in 2026
Published on 03/25/2026 at 18:00, 1 hour 8 minutes ago

LIGHTON: Information concerning the total number of voting rights and shares in the share capital as of 28 february 2026.
Published on 03/25/2026 at 17:51, 1 hour 17 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/25/2026 at 17:40, 1 hour 29 minutes ago

Press release Mobimo: Wangen-Brüttisellen approves Torfmatt project

View all EQS

Published on 03/25/2026 at 18:53, 15 minutes ago

LNA SANTE : 2025 Annual Results
Published on 03/25/2026 at 18:31, 37 minutes ago

Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 1 hour 24 minutes ago

Combined General Meeting on May 05, 2026: publication of the notice of Meeting
Published on 03/25/2026 at 17:45, 1 hour 24 minutes ago

GUILLEMOT CORPORATION: 2025 ANNUAL RESULTS
Published on 03/25/2026 at 17:42, 1 hour 27 minutes ago

2025/2026 Second quarter Sales

View all LES ECHOS COMFI WIRE

News